A recent cohort study evaluating the cardiovascular outcomes associated with ACE inhibitor use among white and black patients has demonstrated that the black patients taking the ACE inhibitors dealt with increased cardiovascular outcomes, such as nonfatal myocardial infarction and nonfatal stroke, compared to white patients [177]. Here, ACE is linked to Stroke.